12 January 2023 in Journal of Health Sciences and Medicine
Aim: The aim of our study is to reveal the factors affecting the clinical course of COVID-19 infection and mortality in immune and non-immune patients aged 65 and over.Material and Method: The study was carried out by scanning the files of a total of 1,642 COVID-19 cases aged 65 and over. The 1337 cases included in the study were divided into two groups as follows: patients who were vaccinated with the 2nd dose of CoronaVac but became infected with COVID-19 after the 14-day period in which immunization should develop (Group I) and the others who were unvaccinated, or infected with COVID-19 after a single dose of vaccination or infected after receiving a 2nd dose of vaccination in 14 days (Group II). The groups were compared with each other about mortality and the factors affecting mortality.Results: The length of intensive care unit (ICU) stay, and the total length of hospital stay were significantly longer in Group II than Group I (p<0.05). The need for mechanical ventilation (MV) and the length of MV were also significantly higher in Group II than Group I (p<0.05). All patients enrolled in the study had lung involvement. The percentage of Computed tomography (CT) involvement over 50% was statistically significant in Group II (p<0.05). The percentage of severe and critically severe patients and mortality were significantly high in Group II vs. Group I (p<0.05).Conclusion: When we compared the vaccinated and unvaccinated groups of 65 years of age, we found that hospitalization in the ICU and the need for MV increased mortality, and the vaccine reduced the need for intensive care and MV.
13 October 2026 in Flora the Journal of Infectious Diseases and Clinical Microbiology
29 June 2026 in Klimik Dergisi/Klimik Journal
Objective: Coagulase-negative staphylococci (CoNS) are leading causes of healthcare-associated bloodstream infections (BSIs) and pose a significant clinical challenge in intensive care units (ICUs). This study aimed to identify clinical and laboratory parameters associated with 30-day mortality in ICU patients with CoNS-related BSI. Methods: This retrospective study included patients aged 18 years or older who were hospitalized in the ICU between January 1 and November 1, 2024, and had the same CoNS species isolated from two separate blood culture sets. Demographic characteristics, clinical findings, laboratory results, and microbiological data were evaluated. Factors associated with 30-day mortality were investigated using receiver operating characteristic (ROC) curve analysis and multivariate logistic regression analysis. Results: A total of 173 patients were included in the study. The median age was 75 years (interquartile range [IQR], 66–81), and 42.8% were female. Staphylococcus epidermidis was the most frequently isolated species (42.2%), and 95.3% of isolates were methicillin-resistant. Septic shock was present in 45% of patients. The 30-day mortality rate was 71.6%. Compared with survivors, nonsurvivors had significantly higher procalcitonin (PCT) levels (1.46 vs 0.58 ng/mL; p=0.002) and lactate levels (2.25 vs 1.97 mmol/L; p=0.044), whereas platelet counts were significantly lower (182 500 vs 282 000/mm³; p<0.001). In multivariate analysis, platelet count ≤194 000/mm³ [odds ratio (OR): 5.94; 95% confidence interval (CI): 2.53–13.97; p0.67 ng/mL (OR: 3.14; 95% CI: 1.50–6.57; p=0.002) were independently associated with 30-day mortality. Conclusion: In patients with CoNS-related BSI, elevated PCT levels and low platelet counts were independently associated with 30-day mortality. These findings may contribute to early prognostic assessment and risk stratification in critically ill patients. Keywords: Bloodstream infection, coagulase-negative staphylococci, mortality, procalcitonin
30 November 2025 in The Journal of Infection in Developing Countries
Introduction: Klebsiella pneumoniae is a common causative agent of hospital-acquired (HA) bloodstream infections (BSI) in intensive care units (ICU). This study aimed to investigate mortality rates and the factors affecting mortality in BSI due to K. pneumoniae acquired in the ICU. Methodology: This retrospective study included adult patients hospitalized in the ICU between January 2021 and December 2022 who developed HA BSI due to K. pneumoniae. The association between clinical characteristics, invasive and medical treatment practices before bacteremia, and 15-day and 30-day mortality was investigated. Results: A total of 232 patients (median age 68.0 years) were included. All-cause mortality rates on days 15 and 30 were 56.0% and 72.8%, respectively. The proportion of patients infected with carbapenem-resistant K. pneumoniae was 77.6%. Logistic regression analysis revealed significant associations between systemic corticosteroid use (OR: 2.38; p = 0.014), high qPitt score (OR: 1.32; p = 0.046), and presence of immunosuppression (OR: 2.70; p = 0.020); and 15-day mortality. Significant associations were found between systemic corticosteroid use (OR: 3.69; p = 0.002), high qPitt score (OR: 1.44; p = 0.043) and presence of immunosuppression (OR: 6.61; p = 0.004); and 30-day mortality. Conclusions: Corticosteroid treatment before the development of bacteremia in ICU patients may contribute to mortality in BSI due to K. pneumoniae. Therefore, corticosteroids should be used with caution despite their benefit in the treatment of acute respiratory distress syndrome. High qPitt scores and the presence of immunosuppression may be used as predictors of mortality in HA BSI due to K. pneumoniae.